Embed Size (px)
Citation preview
Asia Pacific Healthcare Outlook 2012- 2015
What comes next….
Reenita DasSVP Healthcare and Life sciences
What’s Trending for 2012…2015
China will be the largest pharmaceutical and medical devices market in APAC.
Half of the growth in healthcare will come from the “E7”.
Mobile Health to become the biggest business model disruptor creating access for healthcare delivery on a mass basis especially in emerging economies.
Healthcare expenditure in APAC will increase by 75%.
2
Advanced medical technologies will be defined by "lower cost scaled down technology“, reverse innovation will help leapfrog cost barriers.
Surprisingly India is expected to lag behind in all healthcare segments except in Pharmaceuticals.
Competition between Asian diagnostics companies and MNCs will spur innovation.
Gen Y is going to break down some of the organizational sclerosis that is
clogging up our healthcare system.
Health enhancements set to become one of the top 10 market places in healthcare.
Higher proliferation of non - healthcare companies entering healthcare.
2011 2015
Global Reflections from 2011 and the way forward…
Healthcare Evolves to Become a Service Industry“you’re sick…we’re quick”
The flood gate of Health Marts:Mckesson leads the way to consumerizehealthcare
Healthcare
becomes data
driven and
customized. More
focus on cost
versus outcomesSilicon Valley and the Hi-Tech industry gets involved in healthcare
Patients will be Kings and Queens of the healthcare system
1 billion seniors by 2020 and 2 billion by 2050
3
More “generics” –technologies providing same value at lower price, stripped down feature sets
R & D spend is
$ 1.15 trillion up
despite economic
recession
Gold Rush to
Emerging Markets:
Indonesia, Russia,
Mexico, Brazil, India,
Turkey and China –
comprising 1/5th of
the worldwide health
care sales
Diagnostics and Monitoring will become the golden goose
Home healthcare and care givers dominate the agenda
The big Tidal Wave: Performance based Insurance policies
2011 2015
APAC Healthcare market sales will account for 29% in 2011
Growth of mHealth will facilitate penetration of healthcare services
Increase of green technology in
APAC Healthcare market sales comprises 35% in 2015
The Asian perspective… Mobile phone users will rise from 2.2 billion in 2011 to 3.4 billion in 2015
Asian hospitals evolve to become global brands
Multiple partnerships
4
Emergence of New markets: Vietnam, Indonesia, Laos, and Myanmar in development of healthcare infrastructure
Over half of the middle class will be from the APAC region by 2020. Gen Y to drive how healthcare is delivered
technology in manufacturing,logistics and healthcare deliveryMost countries
in APAC would have implemented EMR platforms
Traditional medicine and supplements gaining marketstrength and recognition
partnerships between NGOs, private and government for Asian disease based R&D
APAC Healthcare Expenditure will increase 151% by 2020, while countries with the lowest projected growth rate will be UK, Italy, & Germany
Japan$563 billion
CAGR 3.0%
Hong Kong$20 billion
CAGR 3.2%
South Korea$127 billion
CAGR 5.5%
China$1446 billion
CAGR 15.5%
USA$3922 billionCAGR 4.6%
5
G7$6147 billion
50% increase 2010-2020
CAGR 4.0%
APAC$2927 billion
151% increase 2010-2020
CAGR 9.2%
Australia$198 billion
CAGR 3.0%
Singapore$23 billion
CAGR 9.6%
Malaysia$25 billion
CAGR 8.4%
Taiwan$65 billion
CAGR 7.8%
India$331 billion
CAGR 14.5%
Indonesia$47 billion
CAGR 8.1%
Vietnam$31 billion
CAGR 14.8%
Philippines$26 billion
CAGR 11.5%
Thailand$25 billion
CAGR 8.4%
BRIC$1958 billion
212% increase 2010-2020
CAGR 12.1%
China and Japan Steal the Show by 2015Taiwan/Indonesia catching up in Tier 2 countriesIndia is disappointing despite the hype…
TIER 1 Pharmaceuticals & Biotechnology
MedicalDevices
Medical Imaging
DiagnosticsHealthcare
IT
Total Market Size (2015)
$ 389.4 bil $ 140.0 bil $ 13.4 bil $ 11.0 bil $8.2 bil
1 China China Japan Japan Japan
2 Japan Japan China China Australia
3 India Australia South Korea India Taiwan
4 South Korea South Korea Australia Australia China
6
4 South Korea South Korea Australia Australia China
5 Australia India India South Korea South Korea
TIER 2
1 Taiwan Taiwan Taiwan Indonesia Hong Kong
2 Indonesia Malaysia Malaysia Malaysia Singapore
3 Thailand Thailand Philippines Thailand Malaysia
4 Philippines Indonesia Indonesia Hong Kong Philippines
5 Vietnam Philippines Thailand Vietnam Indonesia
• By 2020, Chronic disease deaths in APAC will grow at 20%.
• 15% of the 37 million deaths worldwide is related to Pandemic and epidemic diseases, 1/3 of such was from APAC.
• Private expenditures is increasing in China and India, private spending accounted for 49.9% and 67.2% respectively in 2009.
Market Drivers
Global vs. APAC: The New FrontierIn 2011, APAC is estimated to be 28.5% of global market
Global & APAC Healthcare Revenues US$ Bn, 2011-2015
895.6928.8
978.11017.5
1060.7
600.0
800.0
1000.0
1200.0
1400.0
1600.0
1800.0
CAGR4.3%
7
• Per capita healthcare expenditure is far below global average (lowest is Vietnam and Indonesia ).
• Shortage of healthcare professionals. Health care workers in APAC is 6.8 per 1,000 population, compared to 18.9 in Europe and 24.8 in the Americas in 2010.
• Access to healthcare and distribution limited in emerging markets.
49.9% and 67.2% respectively in 2009.
Market Restraints
APAC Share28.5 % 34.6%
• By 2015 APAC could represent of global market
356.5 396.4 440.1 491.7 562.1
0.0
200.0
400.0
600.0
2011 2012 2013 2014 2015
APAC($ Billion)
Rest of the World($ Billion)
CAGR12.1%
Chronic disease volume and lack of preventive care in APAC - continuing to drive the Pharma market
Healthcare Industry Size by Product (2015)
23.2%
2.5%
70.7%
1.6% 2.0%
Healthcare Industry Size by Product (2011)
24.7%
2.4%
69.3%
1.6% 2.0%
8
• Pharmaceuticals and Biotechnology segment is growing at 11.5% CAGR.
• Medical devices is growing at 14.0% CAGR.
• Clinical Diagnostics is growing at 11.4% CAGR.
• Medical imaging is growing at 11.2% CAGR.
• HIT is growing at 9.7% CAGR.
Medical Devices Medical Imaging
Pharmaceuticals & Biotechnology Healthcare IT
Clinical Diagnostics
Medical Devices Medical Imaging
Pharmaceuticals & Biotechnology Healthcare IT
Clinical Diagnostics
636.0649.0
677.6707.4
738.5
400.0
600.0
800.0
1,000.0
1,200.0 Market Drivers
Pharmaceuticals & Biotechnology, US$ Bn, 2011-2015
• Increased long term use of multiple and specialized drugs for the aging population.
• Enhanced health awareness and purchasing power boosting over-the-counter purchase.
• Government support for generics/bio-similars.
• Increased disease incidence boosted by availability and usage of new diagnostic
Pharma market will grow at almost triple the rate compared with the rest of the world, accounting for 1/3rd of total by 2015
CAGR3.8%
9
252.1 278.4 309.4 346.1 389.4
0.0
200.0
400.0
2011 2012 2013 2014 2015
APAC($ Billion)
Rest of the World($ Billion)
Market Restraints
APAC Share
availability and usage of new diagnostic tools.
• Patent expiry of major pharmaceutical products.
• Cost control measures by various governments.
• In markets with strong local manufacturing, government tenders favor local manufacturers.
28.4% 34.5%
CAGR11.5%
By 2015, China will become the largest market in APACIndia, Philippines, and Vietnam expected to enjoy double digit CAGR
China
Japan
South Korea,Hong Kong, TaiwanSouth Korea,Hong Kong, Taiwan
US$ 108 billion
US$ 20 billion
US$ 100 billion
US$ 86 billion
CAGR 2%
CAGR 21%
CAGR 7%
Asia Pacific Total Pharmaceutical Market 2011-2015
US$ 184 billion
10
India
Total Pharma market 2011
US$32 billion
Total Pharma market 2015
US$ 16 billion
US$ 15 billion
CAGR 9.6%
Australia
SEA
US$ 23 billion
US$ 12 billion
US$ 16 billion
US$ 11 billion
CAGR 19%
CAGR 2%
� Dengue Vaccine: current demand: 300-400 million; but supply is only: 100 million doses
� Most countries (except China, India, Japan) currently do not have the infrastructure to develop
vaccines
�0
� APAC generics and bio-similars market 2015: ~US$ 203 bn
� China and India are the two biggest markets but Japan’s generic market will grow at CAGR of
9% reaching 12.3 bn in 2015
Generics and
Bio-similars
Generics and
Bio-similars
VaccinesVaccines
Growth opportunities lie in segments that offer innovative products and services to save costs and prevent diseases
11
� HBV: US$ 1.2 bn; CAGR 15%; Pneumococcal Conjugate Vaccine: 442 mn (2010) double digit growth
� Influenza vaccine market: 425 mn CAGR 13.3% (Asia) [Malaysia: 27%, Philippines: 26%, Singapore:
22%]
0
VaccinesVaccines
OncologyOncology
� APAC Oncology market 2015: ~US$ 4.4 bn; up from US$ 3 bn in 2010
� Growth from early diagnosis of cancers and targeted therapy in top 3 types of cancer: lung
cancer, breast cancer and colorectal cancer
• By 2015, Cardiology market is expected to reach $18 billion.
• Surgical procedures are growing at 12.0 %.• Japan and South Korea lead MIS in
APAC, demand for MIS increasing in Singapore, Malaysia, Australia and Thailand, driving devices market.
• Local Asian companies of
Market Drivers
170.92185.07
200.10201.19
208.69
150.0
200.0
250.0
300.0
350.0
400.0
APAC Medical DevicesLocal Asian companies spur growth through low cost products
Medical Devices Revenues, US$ Bn, 2011-2015
CAGR5.1%
12
• Technology based pricing approval remains a hurdle.
• Public hospitals practice- lowest price bidding, leads to price war.
• Inadequate training or certification for allied healthcare staff.
• Local Asian companies of Japan, China, Korea and Taiwan offering cost effective products.
Market Restraints
82.8 94.1 104.1 116.2140.0
0.0
50.0
100.0
2011 2012 2013 2014 2015APAC($ Billion)
Rest of the World($ Billion)
CAGR14.0%CAGR14.0%
26.3 36.6APAC Market Share
By 2012, China’s medical device market size is expected to cross Japan and by 2015, China is expected to lead with 52% market share
China
US$ 32.5 billion
US$ 73.4 billion
CAGR 22.6%
Asia Pacific Top 5 markets of total medical devices market 2011-2015
Japan
US$ 34.8 billion
US$ 42.3 billion
CAGR 5.0%
South Korea
US$ 4.0 billion
CAGR 11.6%
13
Country total market 2011 Country total market 2015
US$ 4.0 billion
US$ 6.1 billion
Australia
US$ 3.0 billion
US$ 4.9 billion
CAGR 13.0%
India
US$ 2.0 billion
US$ 2.8 billion
CAGR 8.5%
� Number of surgeries in hospitals across APAC is estimated to grow at 12.0% by 2015.
� Anesthetics in APAC growing at 12.4% alongside surgical procedures.
� In APAC, cardiology market is expected to reach $18bil by 2015, China leading with an incidence rate of
2.6 mil per year. CardiologyCardiology
Anesthetics & Surgical Anesthetics & Surgical
Population of India, Indonesia, Malaysia, Vietnam, Philippines and Thailand together is estimated to be 1.69 billion but they together represent only
6.7% of the medical devices market
14
0
Orthopedics,
& endoscopy
Orthopedics,
& endoscopy
� Orthopedics market in APAC is growing at 5.0 % CAGR, while endoscopy and laparoscopy is growing at
8.3% CAGR.
� Increase of awareness and availability of affordable, high quality MIS procedures drive these
procedures.
• Increased demand for health screening.• Reverse innovation of customized Asian
medical imaging products to cater for different culture and population.
• R & D in medical imaging allows technological advancement - Molecular Imaging, Drug therapy combined with
Market Drivers
Medical ImagingChina is expected to own 30% of APAC market by 2015…
Medical Imaging Revenues, US$ Bn, 2011-2015
24.0425.00
26.1927.54
28.49
15.0
20.0
25.0
30.0
35.0
40.0
45.0
CAGR4.3%
15
• APAC Refurbished market for imaging equipments is expected to reach 9% growth by 2015.
• System interoperability hinders new systems adoption in hospitals.
Imaging, Drug therapy combined with Ultrasound.
Market Restraints
26.7 32.0APAC Market Share
8.8 9.8 11.0 12.2 13.4
0.0
5.0
10.0
15.0
2011 2012 2013 2014 2015
APAC($ Billion)
Rest of the World($ Billion)
CAGR11.2%CAGR11.2%
China
US$ 2.6 billion
US$ 4.1 billion
CAGR 12.3%
Asia Pacific Top 5 markets of total medical imaging market 2011-2015
Japan
US$ 3.5 billion
US$ 5.5 billion
CAGR 12.0%
South Korea
US$ 0.7 billion
CAGR 11.8%
Japan will continue to lead the APAC Medical Imaging
16
Total country market 2011Total country market 2015
US$ 1.1 billion
Australia
US$ 0.6 billion
US$ 0.7 billion
CAGR 6.2%
India
US$ 0.5 billion
US$ 0.7 billion
CAGR 7.4%
�0
� Mammography is growing at 11.0% in APAC.
� In 2010, Breast Cancer ranked the second major cancer among 7 Asian countries with an incidence
rate of 190,000 cases. By 2015, Breast cancer incidence rate is expected to be 22 affected people per
100,000 population
MammographyMammography
MRI MRI
� MRI market is projected to reach 11.6% CAGR in APAC between 2011-2015.
� Closed MRI systems in Japan represents the largest product category, accounting for an estimated
market share of 82% in 2011.
� Very High Field MRI system is expected to increase in APAC as newer hospitals opt for high-tech
Mammography, MRI and PET scans in medical imaging is expected to rise; as incidence rate for diseases are growing in APAC
17
0
� Very High Field MRI system is expected to increase in APAC as newer hospitals opt for high-tech
imaging machines.
� In 2010, among 7 Asian countries , 960,000 new cases of various types of cancer have been reported.
PET scans application is expected to rise.
� Screening for Neurological disorders and Multiple sclerosis are areas to penetrate.
PET scanPET scan
Market Drivers
Diagnostics Revenues, US$ Bn, 2011-2015
• Government efforts to standardize testing by regulating diagnostic testing and instruments.
• MNCs setting up marketing and manufacturing bases in APAC and providing competition to local diagnostic companies.
• Greater acceptance of technology by physicians and growing awareness of middle class patients.
• The molecular diagnostics market is growing
Japan will continue to lead the APAC market with more than 40% market share
CAGR
CAGR
5.98%
18
Market Restraints
APAC Share
• The molecular diagnostics market is growing by 42% in India and 22.7% in China.
• Limited government budget for diagnostics.• Lack of awareness about healthcare
insurance coverage for clinical tests.• Highly price sensitive market.• Lack of awareness and accessibility of
diagnostic testing in rural areas.
14.5% 17.2%
CAGR
11.44%
China & India will be driving the growth of the Diagnostics market in the next 5 years…
India
US$ 421 million
CAGR 16.1%
Asia Pacific Top 5 markets of total Diagnostics market 2011-2015
Japan
US$ 3.2 billion
US$ 4.5 billion
CAGR 8.7%China
US$ 1.9 billion
US$ 3.7 billion
CAGR 17%
19
Country total market 2011 Country total market 2015
US$ 421 million
US$ 766 million
Korea
US$ 449 million
US$ 564 million
CAGR 5.9%
Australia
US$ 494 million
US$ 624 million
CAGR 6%
• Quality, regulatory and performance application growing at 11.0% CAGR.
• Patient and Revenue cycle management related application will drive HIT with 10.3% CAGR.
• Departmental Systems market size is expected to be $ 875 million in 2011, growing
Market Drivers
APAC HIT growing at global pace of 9.0%. Will APAC jump the curve?
Healthcare IT Revenues, US$ Bn, 2011-2015
22.5025.29
27.0131.00 31.96
15.0
20.0
25.0
30.0
35.0
40.0
45.0
CAGR9.2%
20
• System interoperability hinders market growth.
• Too many small vendors offering HIT solutions.
expected to be $ 875 million in 2011, growing at 7.1%.
Market Restraints
20.2 20.5APAC Market Share
5.7 6.2 6.8 7.5 8.2
0.0
5.0
10.0
2011 2012 2013 2014 2015
APAC($ Billion)
Rest of the World($ Billion)
CAGR9.7%
CAGR9.7%
Japan & Australia leading the HIT market in 2015, Australia is growing faster and Taiwan is catching up…
South Korea
US$ 0.3 billion
CAGR 7.4%
Asia Pacific Top 5 markets of total HIT market 2011-2015
Japan
US$ 1.7 billion
US$ 2.0 billion
CAGR 5.0%China
US$ 0.6 billion
US$ 1.0 billion
CAGR 13.7%
21
Country total market 2011 Country total market 2015
US$ 0.3 billion
US$ 0.4 billion
Taiwan
US$ 0.7 billion
US$ 1.2 billion
CAGR 11.4%Australia
US$ 1.3 billion
US$ 2.0 billion
CAGR 10.7%
APAC HIT Top 3 areas for growth potential...
Application Potential by Growth Rate
Patient and Physician Services
Patient and Revenue Cycle Management
Quality, Regulatory and
Performance
AP
AC
MA
RK
ET 10.33%
CAGR10.00%CAGR
11.03%CAGR
22
AP
AC
MA
RK
ET
Healthcare Interoperability
Platform
EHRDepartmental Systems
Application Potential by Market Size in 2011
CAGR CAGR
$517 mil(2.98%)
$875 mil(7.11%)
$725 mil(5.40%)
CAGR
Where to place your bets in APAC: 2012- 2015 G
row
th
Silver Industry
Equipment
Mobile
Healthcare
Biosimilars
Vaccines
EMR/
EHR
IndiaChina
S.Korea
SingaporeMalaysia Vietnam
Hospital
Taiwan
Australia
Japan
Robotic surgery
Preventive healthcare &
Wellness monitoring
Philippines
Indonesia
Thailand
23
Time
Gro
wth
Molecular
Diagnostics
Equipment
(home care) MIS
Traditional pharmaceuticals
INNOVATIONTRIGGER
SUPERGROWTH
NORMALISATION LEADERSHIP
Source: Frost & Sullivan.
Hospital
Services
Digital
Imaging
Telemedicine
Thank You
24
Thank You
Asia Pacific Healthcare Delivery Outlook Asia Pacific Healthcare Delivery Outlook 2012 2012 –– 20152015
At the cusp of transformation and At the cusp of transformation and consumerisationconsumerisation
Rhenu BhullerVP, Healthcare Asia Pacific
December 2011
2015…
Delivery of health at home
Consolidation of retail healthcare service model
Integration of primary and secondary healthcare facilities. Establishment of electronic medical records integrating primary and secondary healthcare
Satellite based hospital model using advanced medical technologies for increasing accessibility in rural areas
“We Accelerate Growth”26
Healthcare as a service industry
Influx of non-traditional healthcare institutions investments
New models of Holistic healthcare hubs integrating tertiary care, wellness, aged care and clinical R&D
Increasing funding opportunity for medical tourism through expanded international medical insurance
Differentiation of hospital models through specialty or holistic health platforms
Rising middle and affluent income population fueling market growth
309334
362390
420
300
350
400
450
500 CAGR 8.0%
APAC Healthcare Delivery Market Size US$ Bn, 2011-2015
Market Drivers
• Aging & growing
Population
• Rise in chronic disease
• Manpower shortage
• Access disparity between
urban & rural regions
• Manpower shortage
• Access disparity between
urban & rural regions
Market Restraints
“We Accelerate Growth”27
-
50
100
150
200
250
2011 2012 2013 2014 2015
Note: All figures are rounded; the base year is 2009Source: Frost & Sullivan
• Rise in chronic disease
• Medical Tourism
• Rising middle and affluent
income population
urban & rural regions
• Inability to meet demand
of healthcare services in
smaller cities and rural
areas
urban & rural regions
• Inability to meet demand
of healthcare services in
smaller cities and rural
areas
300 new public hospitals by 2012 in China
South Korea - 2015Public: 68,745 (CAGR:1.8%)
Private: 482,436 (CAGR:4.2%)
India - 2015Public:374,670(CAGR:1.6%)
Private:270,098(CAGR:3.2%)
China - 2015Public:3,057,442(CAGR:4.9%)
Private:191,038(CAGR:2.1%)
Indonesia - 2015Public :1,07,796
Projected Number of Hospital Beds - 2015
“We Accelerate Growth”28
Singapore - 2015Public :9,867 (CAGR:2.1%)
Private :3,181 (CAGR:3.8%)
(CAGR:4.3%)
Private:60,813 (CAGR:3.9%)
Philippines - 2015Public:51,204 (CAGR:1.2%)
Private: 58,524 (CAGR:3.0%)
Thailand - 2015Public:87,516(CAGR:2.6%)
Private:36,820(CAGR:1.8%)
International Accreditations
JCI accredited hospitals in APAC have increased by almost 7-fold over the past 6 years
JCI Accredited Hospitals in Key Asian Countries, 2005 - 2011
I
M
• International accreditations (e.g. JCI) likely to become the prerequisite for hospitals targeting to participate in medical tourism
2425
30
2005 2011 JCI Accredited Hospitals in Asia
2005 2011
15 115
“We Accelerate Growth”29
M
P
A
C
T
tourism
• Stringent operational and stringent accreditation requirements likely to escalate the clinical and operational quality standards, thus increasing market competitiveness
01
0
2
0
2
9
1
9
5
17
1213
20
15
0
5
10
15
20
0 1 2 3 4 5 6 7 8 9
S. Korea China SporeIndiaMsia ThaiTaiwanPhil
Hospital group consolidation to stretch beyond regional borders
Hospital Consolidation / diversification
� Liberalisation of services sector under ASEAN Economic Community (AEC): Investors will be ableto hold over 70 percent stake in four major services sectors, including healthcare
� Hospitals are diversifying to increase competitiveness (e.g. Bangkok Dusit aggressive increase oninvestment in non-core medical businesses, from USD 16.6 mil to USD 133.3 mil)
Year Region Description
2011 Singapore, Thailand
• Several Institutional investors (including Temasek Holdings) sold 5.85% stake in Bumrungrad
• More hospital group consolidation likely to stretch beyond regional borders
“We Accelerate Growth”30
Thailand Holdings) sold 5.85% stake in Bumrungrad Hospital
2011 Japan, Malaysia
• Mitsui acquired 30% stake in Integrated Healthcare Holdings (healthcare investment arm of Khazanah)
2011 India,SingaporeHong Kong
• Fortis Healthcare acquired Quality HealthCare Asia in Hong Kong and Dental Corporation
• Fortis agreed to pay half a billion US Dollar to buy Singapore-based Fortis Healthcare International PTE from investment company RHC in Mauritius
2011 SingaporeTurkey
• Parkway Singapore plans to buy stake in Turkish hospital group Acibadem; Acibadem runs 11 general hospitals, 8 medical centers and a laboratory and genetic diagnostic center in Turkey
I
M
P
A
C
T
borders
• More non-traditional healthcare players are likely to acquire stakes in health institutions; or vice versa, where traditional hospital players are extended to other healthcare related fields (e.g. health education, clinical research or medical device R&D)
• New found risks and challenges due to operations in unfamiliar territories
Key Markets Healthcare Environments
India China Indonesia Malaysia Thailand Australia Singapore
Aging Population No Yes No Yes Yes Yes Yes
Dominant Distributer ofPHI
Life/ Non Life/ Health
Life/ Non Life/ Health
Life Life Life Health Life
Aging population driving the change in healthcare service delivery
“We Accelerate Growth”31
Tax Incentives for PHI Yes Group No Yes No Yes Yes
Restrictions on PremiumRates
Notify No No No No Yes notify
Guaranteed Renewal Some Some No No No Yes
Group biz as % of totalportfolio
45% 30% >20% 30% 20% <10% 25%
“Paper-less Healthcare”
Singapore expected to achieved full EMR implementation by 2013
Singapore
Key Markets
I
M
• Improved operational and cost efficiency for healthcare providers
• Increased competitiveness for medical tourism
� Expected to achieved full EMR implementation (100% paperless) by 2013
� Currently fully integrated EMR between hospitals and polyclinics� Moving towards final phase of EMR integration with private GPs� Pipeline: National Tele-health and cloud computing integration
China
� HCIT implementation undertaken at institutional levels ,as part of China’s USD 124 billion Healthcare Reform
� High potential - Average 950 patients per physician per month
“We Accelerate Growth”32
S. Korea
M
P
A
C
T
medical tourism sectors
• EMR implementation is intended to enhance efficiency would pose new challenges to healthcare operators
� Government’s push for EMR penetration through pilot projects (e.g. U-Health)
� Adoption of EMR for tertiary hospitals has increased from 21.4% in 2005 to 77.3% in 2010
Taiwan
� Driven by 2008 Health Care Innovating Service Program � Taiwan Electronic Medical Record Template (TMT) to increase
Interoperability for national-wide through a portable and interoperable infrastructure for EMR exchange
China � High potential - Average 950 patients per physician per month (compared to 400 in the US) treated at more than 20,000 hospitals in China and most of which are still maintaining paper based patient data
Where to place your bets in APAC: 2012-2015G
row
th
Retail healthcare service
Preventive Healthcare
Wellness
Monitoring
Home Healthcare
Service Delivery
Medical insurance portability
Internationally Accredited
Healthcare Service Facilities
IndiaChina
S.Korea
SingaporeMalaysia
Vietnam
Australia
Japan
Thailand
Indonesia
Philippines
Asia Pacific
Mobile Healthcare
Specialty based hospitals
vs. Holistic wellness hospitals
“We Accelerate Growth”33
Time
Gro
wth
Retail healthcare service
Primary and Diagnostic
stand alone centers
Satellite based
hospital model
INNOVATIONTRIGGER
SUPERGROWTH
NORMALISATION LEADERSHIP
Source: Frost & Sullivan.
Tier2 and Tier3
Healthcare Service
Center development
Frost & SullivanAn Active Contributor to Global HC Market Development
Comprehensive
Supply-side Analysis
Robust
Hosting Industry
Forums
Strategic
Expert Analysis
Recognizing
Best Practices
“We Accelerate Growth”34
Robust
End-user
Analysis
Thought
Leadership
Forums
Thank You
“We Accelerate Growth”35
Thank You
Follow Frost & Sullivan on Facebook, LinkedIn, SlideShare, and Twitter
http://www.facebook.com/FrostandSullivan
http://www.linkedin.com/companies/4506
“We Accelerate Growth”36
http://twitter.com/frost_sullivan
http://www.linkedin.com/companies/4506
http://www.slideshare.net/FrostandSullivan
For Additional Information
Donna Jeremiah
Corporate Communications
Asia Pacific
+603 6204 5832
Carrie Low
Corporate Communications
Asia Pacific
+603 6204 5910
“We Accelerate Growth”37
Jessie Loh
Corporate Communications
Asia Pacific
+65 6890 0942
